{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:49:18Z","timestamp":1784371758357,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015077","name":"Jagiellonian University in Krak\u00f3w School of Medicine","doi-asserted-by":"publisher","award":["K\/ZDS\/005802"],"award-info":[{"award-number":["K\/ZDS\/005802"]}],"id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015077","name":"Jagiellonian University in Krak\u00f3w School of Medicine","doi-asserted-by":"publisher","award":["N41\/DBS\/001300"],"award-info":[{"award-number":["N41\/DBS\/001300"]}],"id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.thromres.2025.109551","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:35:27Z","timestamp":1763771727000},"page":"109551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["FVIIa-AT complexes in patients with acute ischemic stroke: Impact on clinical outcomes"],"prefix":"10.1016","volume":"257","author":[{"given":"Marek","family":"Kachnic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Matysiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Natorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Bembenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Szczygie\u0142-Pilut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109551_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.str.0000437068.30550.cf","article-title":"Factors influencing the decline in stroke mortality: a statement from the American Heart Association\/American Stroke Association","volume":"45","author":"Lackland","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0010","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e318206ca1e","article-title":"Three-month stroke outcome: the European Registers of Stroke (EROS) Investigators","volume":"76","author":"Heuschmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2025.109551_bb0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","article-title":"Tissue factor in coagulation: Which? Where? When?","volume":"29","author":"Butenas","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2025.109551_bb0025","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.blre.2013.03.001","article-title":"The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis","volume":"27","author":"Winckers","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2025.109551_bb0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1515\/cclm-2016-0399","article-title":"Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation","volume":"55","author":"Spiezia","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.thromres.2025.109551_bb0040","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1161\/STROKEAHA.113.000736","article-title":"Brain regulation of thrombosis and hemostasis from theory to practice","volume":"44","author":"Fisher","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2025.109551_bb0050","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/STROKEAHA.115.008678","article-title":"Circulating tissue factor levels and risk of stroke: findings from the EPICOR study","volume":"46","author":"Iacoviello","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0055","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5114\/aoms.2015.54791","article-title":"Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke","volume":"12","author":"Kusak","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.thromres.2025.109551_bb0060","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.thromres.2011.06.010","article-title":"Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events","volume":"128","author":"Undas","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109551_bb0065","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1160\/TH09-08-0606","article-title":"Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis","volume":"103","author":"Spiezia","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1076029616631424","article-title":"Assessing circulating factor VIIa-antithrombin complexes in acute ischemic stroke: a pilot study","volume":"23","author":"Slomka","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109212","article-title":"Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - a sub-study of the MR CLEAN NO-IV trial","volume":"245","author":"Ceulemans","year":"2025","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109551_bb0080","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1160\/TH16-12-0954","article-title":"Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome","volume":"117","author":"Bembenek","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0085","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1161\/STROKEAHA.123.043628","article-title":"Protein carbonylation contributes to prothrombotic fibrin clot phenotype in acute ischemic stroke: clinical associations","volume":"54","author":"B\u0142a\u017c","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0090","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.jtha.2024.06.028","article-title":"Elevated lipopolysaccharide level is largely driven by time since symptom onset in acute ischemic stroke: the impact on clinical outcomes","volume":"22","author":"B\u0142a\u017c","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0095","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","article-title":"Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the european cooperative acute stroke study","volume":"28","author":"Larrue","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials - a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0110","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2025.109551_bb0115","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"John Camm","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2025.109551_bb0120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"Mcmurray","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.thromres.2025.109551_bb0125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.thromres.2025.109551_bb0130","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","article-title":"Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction","volume":"34","author":"Becatti","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2025.109551_bb0135","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/diagnostics14161711","article-title":"Activated factor VII-antithrombin complex, a biomarker of tissue factor-related pathways in different clinical settings: a narrative review from cardiovascular diseases to cancer","volume":"14","author":"Moruzzi","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.thromres.2025.109551_bb0140","series-title":"Blood Vessels, Thrombosis & Hemostasis","article-title":"Challenges with measuring tissue factor antigen and activity in human plasma","volume":"1","author":"Mackman","year":"2024"},{"key":"10.1016\/j.thromres.2025.109551_bb0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","article-title":"HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease","volume":"13","author":"Festoff","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.thromres.2025.109551_bb0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/jth.13274","article-title":"Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study","volume":"14","author":"Martinelli","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0155","article-title":"Factor VIIa-Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype","author":"Bazan-Socha","year":"2025","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109551_bb0160","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12933-024-02480-z","article-title":"Good metabolic control is associated with decreased circulating factor VIIa-antithrombin complexes in type 2 diabetes: a cross-sectional study","volume":"23","author":"Gasto\u0142","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2025.109551_bb0165","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/STROKEAHA.111.622217","article-title":"Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases","volume":"43","author":"Tj\u00e4rnlund-Wolf","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109551_bb0170","first-page":"16884","article-title":"Novel factors affecting fibrin clot formation and their clinical implications","volume":"134","author":"Z\u0105bczyk","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109551_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice","volume":"119","author":"Z\u0105bczyk","year":"2023","journal-title":"Cardiovasc. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:34:01Z","timestamp":1771724041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0049384825003019"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109551","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FVIIa-AT complexes in patients with acute ischemic stroke: Impact on clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109551"}}